Piekos Brian
- SEC CIK
- 0001815308
In the past year, 4 open-market sale filings worth $165.2K and no purchases.
Current role at each company
- KALV KalVista Pharmaceuticals, Inc.Chief Financial Officeras of Jun 11, 2026
- ELTX Elicio Therapeutics, Inc.Chief Financial Officeras of Feb 5, 2024
- IRON Disc Medicine, Inc.CFOas of Jun 2, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $165.2K
- 4 filings
- Net
- −$165.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Piekos Brian as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KALV KalVista Pharmaceuticals, Inc.
Chief Financial Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 (view filing) | May 22 | 4 days | Piekos BrianChief Financial Officer | SSale | −1.49K | $26.78 | −$39.9K | −6.4%21.7K after | |
| Apr 20, 2026 (view filing) | Apr 17 | 3 days | Piekos BrianChief Financial Officer | SSale | −1.86K | $20.22 | −$37.6K | −9.3%18.1K after | |
| Feb 24, 2026 (view filing) | Feb 23 | 1 day | Piekos BrianChief Financial Officer | SSale | −1.77K | $15.57 | −$27.5K | −11.4%13.8K after | |
| Nov 26, 2025 (view filing) | Nov 24 | 2 days | Piekos BrianChief Financial Officer | SSale | −4.47K | $13.45 | −$60.1K | −29.8%10.5K after |